Avidity Partners Management LP Ideaya Biosciences, Inc. Transaction History

Avidity Partners Management LP

$885 Million
Q4 2024

A detailed history of Avidity Partners Management LP transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 1,126,700 shares of IDYA stock, worth $23.7 Million. This represents 3.27% of its overall portfolio holdings.

Number of Shares

1,126,700

Previous 1,373,000 17.94%

Holding current value

$23.7 Million

Previous $43.5 Million 33.43%

% of portfolio

3.27%

Previous 2.67%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$24.79 - $31.98 $6.11 Million - $7.88 Million	-246,300 Reduced 17.94%	1,126,700 $29 Million
Q3 2024 Nov 14, 2024	BUY	$30.37 - $43.05 $7.77 Million - $11 Million	256,000 Added 22.92%	1,373,000 $43.5 Million
Q2 2024 Aug 14, 2024	BUY	$34.37 - $43.46 $10.9 Million - $13.8 Million	317,300 Added 39.68%	1,117,000 $39.2 Million
Q1 2024 May 15, 2024	SELL	$34.2 - $47.13 $24.6 Million - $33.9 Million	-720,300 Reduced 47.39%	799,700 $35.1 Million
Q4 2023 Feb 14, 2024	SELL	$24.59 - $35.83 $15.4 Million - $22.4 Million	-624,971 Reduced 29.14%	1,520,000 $54.1 Million
Q3 2023 Nov 14, 2023	SELL	$21.07 - $29.77 $17.7 Million - $25 Million	-840,729 Reduced 28.16%	2,144,971 $57.9 Million
Q2 2023 Aug 14, 2023	SELL	$13.33 - $25.53 $9.17 Million - $17.6 Million	-687,700 Reduced 18.72%	2,985,700 $70.2 Million
Q1 2023 May 15, 2023	SELL	$13.49 - $18.72 $2.04 Million - $2.83 Million	-151,400 Reduced 3.96%	3,673,400 $50.4 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $1.58 Million - $1.99 Million	109,400 Added 2.94%	3,824,800 $69.5 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $6.86 Million - $11.7 Million	742,453 Added 24.97%	3,715,400 $55.4 Million
Q2 2022 Aug 15, 2022	BUY	$8.28 - $13.88 $2.34 Million - $3.93 Million	282,947 Added 10.52%	2,972,947 $41 Million
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $1.53 Million - $3.29 Million	137,000 Added 5.37%	2,690,000 $30.1 Million
Q4 2021 Feb 14, 2022	BUY	$20.95 - $26.88 $2.43 Million - $3.12 Million	116,000 Added 4.76%	2,553,000 $60.4 Million
Q3 2021 Nov 15, 2021	BUY	$17.26 - $27.08 $6.33 Million - $9.94 Million	367,000 Added 17.73%	2,437,000 $62.1 Million
Q2 2021 Aug 16, 2021	BUY	$17.76 - $24.83 $10.6 Million - $14.8 Million	598,000 Added 40.63%	2,070,000 $43.4 Million
Q1 2021 May 17, 2021	BUY	$13.48 - $23.77 $19.8 Million - $35 Million	1,472,000 New	1,472,000 $34.6 Million
Q4 2020 Feb 16, 2021	SELL	$12.17 - $17.52 $12.8 Million - $18.4 Million	-1,050,800 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.22 - $14.46 $3.14 Million - $4.05 Million	-280,300 Reduced 21.06%	1,050,800 $13.2 Million
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $4.78 Million - $24.7 Million	1,331,100 New	1,331,100 $18.9 Million

Others Institutions Holding IDYA

# of Institutions

216

Shares Held

82.4M

Call Options Held

23.1K

Put Options Held

6.7K

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.01B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Ideaya Biosciences, Inc. Transaction History